{
    "id": 22979,
    "fullName": "WNT1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "WNT1 over exp indicates an over expression of the Wnt1 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 7471,
        "geneSymbol": "WNT1",
        "terms": [
            "WNT1",
            "BMND16",
            "INT1",
            "OI15"
        ]
    },
    "variant": "over exp",
    "createDate": "05/26/2016",
    "updateDate": "01/03/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6541,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of E7449 and E6201 inhibited tumor growth in subcutaneous models of WNT1-transgenic mouse mammary tumors, with increased efficacy over either agent alone (PMID: 26513298).",
            "molecularProfile": {
                "id": 23622,
                "profileName": "WNT1 over exp"
            },
            "therapy": {
                "id": 4145,
                "therapyName": "E6201 + E7449",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4121,
                    "pubMedId": 26513298,
                    "title": "E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26513298"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12644,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, SJ26 inhibited cell migration of breast cancer cells in culture, with overexpression of Wnt1 (PMID: 27626678).",
            "molecularProfile": {
                "id": 23622,
                "profileName": "WNT1 over exp"
            },
            "therapy": {
                "id": 6546,
                "therapyName": "SJ26",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10524,
                    "pubMedId": 27626678,
                    "title": "Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27626678"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12643,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, SJ26 inhibited cell migration of NSCLC cells in culture, with overexpression of Wnt1 (PMID: 27626678).",
            "molecularProfile": {
                "id": 23622,
                "profileName": "WNT1 over exp"
            },
            "therapy": {
                "id": 6546,
                "therapyName": "SJ26",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10524,
                    "pubMedId": 27626678,
                    "title": "Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27626678"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6543,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, E7449 did not inhibit tumor growth in subcutaneous models of WNT1-transgenic mouse mammary tumors (PMID: 26513298).",
            "molecularProfile": {
                "id": 23622,
                "profileName": "WNT1 over exp"
            },
            "therapy": {
                "id": 724,
                "therapyName": "E7449",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 4121,
                    "pubMedId": 26513298,
                    "title": "E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26513298"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6544,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, WNT-C59 inhibited tumor growth in subcutaneous models of WNT1-transgenic mouse mammary tumors (PMID: 26513298).",
            "molecularProfile": {
                "id": 23622,
                "profileName": "WNT1 over exp"
            },
            "therapy": {
                "id": 3775,
                "therapyName": "WNT-C59",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4121,
                    "pubMedId": 26513298,
                    "title": "E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26513298"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12645,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, SJ26 inhibited cell migration of liver cancer cells in culture, with overexpression of Wnt1 (PMID: 27626678).",
            "molecularProfile": {
                "id": 23622,
                "profileName": "WNT1 over exp"
            },
            "therapy": {
                "id": 6546,
                "therapyName": "SJ26",
                "synonyms": null
            },
            "indication": {
                "id": 3571,
                "name": "liver cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10524,
                    "pubMedId": 27626678,
                    "title": "Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27626678"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23622,
            "profileName": "WNT1 over exp",
            "profileTreatmentApproaches": [
                {
                    "id": 16656,
                    "name": "WNT Inhibitor",
                    "profileName": "WNT1 over exp"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}